[go: up one dir, main page]

MX2022011901A - Arilo piperidinas como moduladores de monoacilglicerol lipasa. - Google Patents

Arilo piperidinas como moduladores de monoacilglicerol lipasa.

Info

Publication number
MX2022011901A
MX2022011901A MX2022011901A MX2022011901A MX2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A MX 2022011901 A MX2022011901 A MX 2022011901A
Authority
MX
Mexico
Prior art keywords
sup
disorders
modulators
methods
monoacyl glycerol
Prior art date
Application number
MX2022011901A
Other languages
English (en)
Inventor
Michael K Ameriks
Pablo Garcia-Reynaga
Cynthia B Berry
Krisztián Biró
Andrew V Samant
Warren S Wade
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2022011901A publication Critical patent/MX2022011901A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuestos de arilo piperidina de la Fórmula (I), y sales, isótopos, N-óxidos, solvatos, y estereoisómeros farmacéuticamente aceptables de estos, composiciones farmacéuticas que los contienen, y métodos para usarlos que incluyen métodos para tratar estados de enfermedad, trastornos y afecciones asociados con la modulación de la MGL, tales como aquellos asociados con dolor, trastornos psiquiátricos, trastornos neurológicos (que incluyen, pero no se limitan a, trastorno depresivo mayor, depresión resistente al tratamiento, depresión ansiosa, trastornos del espectro autista, síndrome de Asperger, trastorno bipolar), cánceres y afecciones oculares: (ver fórmula); en donde X, R2a, R2b, R3, R4, R5a y R5b, se definen en la presente descripción.
MX2022011901A 2020-03-26 2021-03-25 Arilo piperidinas como moduladores de monoacilglicerol lipasa. MX2022011901A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063000282P 2020-03-26 2020-03-26
PCT/EP2021/057820 WO2021191384A1 (en) 2020-03-26 2021-03-25 Aryl piperidines as monoacylglycerol lipase modulators

Publications (1)

Publication Number Publication Date
MX2022011901A true MX2022011901A (es) 2023-01-04

Family

ID=75302569

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011901A MX2022011901A (es) 2020-03-26 2021-03-25 Arilo piperidinas como moduladores de monoacilglicerol lipasa.

Country Status (10)

Country Link
US (2) US11787798B2 (es)
EP (1) EP4126840A1 (es)
JP (1) JP7729832B2 (es)
KR (1) KR20220158060A (es)
CN (1) CN115362151B (es)
AU (1) AU2021243726A1 (es)
BR (1) BR112022019155A2 (es)
CA (1) CA3177058A1 (es)
MX (1) MX2022011901A (es)
WO (1) WO2021191384A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7795466B2 (ja) 2020-02-10 2026-01-07 ヤンセン ファーマシューティカ エヌ．ベー． モノアシルグリセロールリパーゼ調節因子
JP7777083B2 (ja) * 2020-03-26 2025-11-27 ヤンセン ファーマシューティカ エヌ．ベー． モノアシルグリセロールリパーゼ調節因子としてのアザスピロ環化合物
MX2022011901A (es) 2020-03-26 2023-01-04 Janssen Pharmaceutica Nv Arilo piperidinas como moduladores de monoacilglicerol lipasa.
EP4126825A1 (en) 2020-03-26 2023-02-08 Janssen Pharmaceutica NV Aminocyclobutanes as monoacylglycerol lipase modulators
WO2023130023A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60332816D1 (de) 2002-03-13 2010-07-15 Schering Corp Nk1-antagonisten
EP1527074A1 (en) 2002-07-25 2005-05-04 Pharmacia Italia S.p.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
EP2090576A1 (en) 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
US8435977B2 (en) * 2009-04-22 2013-05-07 Janssen Pharmaceutica, Nv Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
CN103957916A (zh) 2011-09-30 2014-07-30 詹森药业有限公司 用于治疗代谢疾病和相关失调的单酰甘油脂肪酶抑制剂
GB201504675D0 (en) 2015-03-19 2015-05-06 Heptares Therapeutics Ltd Pharmaceutical compounds
KR102698366B1 (ko) 2015-08-04 2024-08-26 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 피라졸 피리미딘 유도체 및 이의 용도
DK3436444T3 (da) * 2016-03-31 2020-07-27 Takeda Pharmaceuticals Co Heterocyklisk forbindelse
WO2017170830A1 (ja) 2016-03-31 2017-10-05 武田薬品工業株式会社 複素環化合物
EP3689879B1 (en) 2017-09-29 2025-02-12 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN112272670B (zh) 2019-04-16 2023-12-12 上海翰森生物医药科技有限公司 含二并环类衍生物抑制剂、其制备方法和应用
JP7795466B2 (ja) 2020-02-10 2026-01-07 ヤンセン ファーマシューティカ エヌ．ベー． モノアシルグリセロールリパーゼ調節因子
MX2022011901A (es) * 2020-03-26 2023-01-04 Janssen Pharmaceutica Nv Arilo piperidinas como moduladores de monoacilglicerol lipasa.
EP4126825A1 (en) 2020-03-26 2023-02-08 Janssen Pharmaceutica NV Aminocyclobutanes as monoacylglycerol lipase modulators
JP7777083B2 (ja) 2020-03-26 2025-11-27 ヤンセン ファーマシューティカ エヌ．ベー． モノアシルグリセロールリパーゼ調節因子としてのアザスピロ環化合物

Also Published As

Publication number Publication date
CN115362151B (zh) 2025-02-11
BR112022019155A2 (pt) 2022-12-06
WO2021191384A1 (en) 2021-09-30
KR20220158060A (ko) 2022-11-29
EP4126840A1 (en) 2023-02-08
CA3177058A1 (en) 2021-09-30
US11787798B2 (en) 2023-10-17
CN115362151A (zh) 2022-11-18
JP2023518515A (ja) 2023-05-01
US20240092781A1 (en) 2024-03-21
AU2021243726A1 (en) 2022-09-29
US20220363679A1 (en) 2022-11-17
JP7729832B2 (ja) 2025-08-26

Similar Documents

Publication Publication Date Title
MX2022011901A (es) Arilo piperidinas como moduladores de monoacilglicerol lipasa.
MX2022011904A (es) Aminociclobutanos como moduladores de monoacilglicerol lipasa.
MX2022011903A (es) Azaspirociclos como moduladores de monoacilglicerol lipasa.
MX2022011902A (es) Moduladores de la monoacilglicerol lipasa.
SA521421575B1 (ar) مُعدلات ليباز أُحادِيُّ الجلِيسِريد
CR20220376A (es) Moduladores de la monoacilglicerol lipasa
MX2023003240A (es) Moduladores de monoacilglicerol lipasa de ciclobutilamida.
MX2021003661A (es) Moduladores de la monoacilglicerol lipasa.
GEAP202416430A (en) N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
JP2017503025A (ja) 神経形成を刺激することができるｎ−フェニル−ラクタム誘導体及び神経障害の処置におけるそれらの使用
EA201992127A1 (ru) ФАРМАКОЛОГИЧЕСКИ АКТИВНЫЕ АЛИЦИКЛИЧЕСКИ ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА
WO2023115060A1 (en) Psychoplastogens for treating hearing-related disorders
MX2024010344A (es) Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa
MX2023003165A (es) Moduladores de la caseína cinasa 1 delta.
MX2023009285A (es) Compuestos novedosos.
MX2023003170A (es) Moduladores de la caseina cinasa 1 delta.
JP2004527562A (ja) ニコチン性アセチルコリンレセプターリガンドおよび／またはセロトニン作動性リガンドとしての６Ｈ−オキサゾロ［４，５−ｅ］インドール誘導体
MX2023011991A (es) Moduladores de receptor 1 asociado a las aminas trazas (taar1) y serotonina, y composiciones farmacéuticas, y métodos de uso de estos.
AR128494A1 (es) Compuestos heterocíclicos, composiciones de los mismos y métodos de tratamiento con los mismos
US20200392126A1 (en) Isoxazolyl compounds as receptor modulating compounds and methods and uses thereof
PE20251399A1 (es) Derivados de tetrahidrotiazepina biciclicos
de Oliveira Martins Uso do laser de baixa intensidade e os mecanismos celulares e moleculares no processo de reparação no sistema nervoso periférico.
EP2703402A1 (en) Pharmacologically active alicyclic n,n'-substituted 3,7-diazabicyclo[3.3.1]nonane derivatives and drugs based thereon